English News

  • youtube
  • facebook
  • twitter

Bharat Biotech’s Intranasal Covid Vaccine Gets Approval For Phase III Trials

With Drugs Controller General of India’s (DCGI) green light, Bharat Biotech receives approval to conduct Phase-III clinical trials of an intranasal booster dose on people who have received both doses of Covaxin. Trials will be conducted at 9 locations across the country. Watch to know more!